TRAF3 and viral infectious disease: Our work suggests that a macrophage made “tolerant” by exposure to TLR2 ligands may, in fact, selectively prime some classes of promoters, such as those responsive to IRF3, by up-regulating certain downstream signaling nodes (e.g., TRAF3) and in this way render the host hyper-vigilant to viral infection.